biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Hummm,,,a merger or a buy out?

<< Previous

Bullboard Posts

Next >>

Comment by narmacon Dec 15, 2022 3:21pm

116 Views

Post# 35174071

RE:RE:Hummm,,,a merger or a buy out?

Would you consider doing this Narmac? Send questions to Graeme,,,,,???

Yep,,no problem,,, it has been suggested by Graeme that I send a list to him,,,,I assume SH is a board which is read by all sides in this deal,,,,,,so lets put a max of 10 of our best questions in! ,,

Ok??

<< Previous

Bullboard Posts

Next >>

Options trading in a volatile macro environment